Litcius/Paper detail

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, Corrina Fonseca, Leonardo Iaccarino, Amy Wolf, Salvatore Spina, Isabel Elaine Allen, Yann Cobigo, Hilary W. Heuer, Lawren VandeVrede, Nicholas K. Proctor, Argentina Lario Lago, Suzanne L. Baker, Rajeev Sivasankaran, Agnieszka Kieloch, Arvind G. Kinhikar, Lili Yu, Marie‐Anne Valentin, Andreas Jeromin, Henrik Zetterberg, Oskar Hansson, Niklas Mattsson, Danielle Graham, Kaj Blennow, Joel H. Kramer, Lea T. Grinberg, William W. Seeley, Howard J. Rosen, Bradley F. Boeve, Bruce L. Miller, Charlotte E. Teunissen, Gil D. Rabinovici, Julio C. Rojas, Jeffrey L. Dage, Adam L. Boxer

2021The Lancet Neurology594 citationsDOIOpen Access PDF

Topics & Concepts

Frontotemporal lobar degenerationPhosphorylationFrontotemporal dementiaMedicineDiseaseNeuroscienceInternal medicinePsychologyChemistryBiochemistryDementiaDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study | Litcius